Interpace Biosciences Inc. (IDXG)

[Renegades17]

Perhaps I am

But I see a company with 30-50% y/y revenue growth, expanding gross margins, narrowing operating losses and approaching cash flow breakeven. Perhaps I am missing something, but like I said, I could rationalize the prior three offerings. This most recent one perplexes me and the only explanation I have is that there is an M&A opportunity that they need to act on in short order.